Halyard Health Company Profile (NYSE:HYH)

About Halyard Health (NYSE:HYH)

Halyard Health logoHalyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment's products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:HYH
  • CUSIP: N/A
  • Web: www.halyardhealth.com
Capitalization:
  • Market Cap: $1.84166 billion
  • Outstanding Shares: 46,700,000
Average Prices:
  • 50 Day Moving Avg: $38.83
  • 200 Day Moving Avg: $38.46
  • 52 Week Range: $31.59 - $41.84
P/E:
  • Trailing P/E Ratio: 48.04
  • Foreward P/E Ratio: 19.43
  • P/E Growth: 5.23
Sales & Book Value:
  • Annual Revenue: $1.6 billion
  • Price / Sales: 1.15
  • Book Value: $24.22 per share
  • Price / Book: 1.63
Profitability:
  • EBIDTA: $166.4 million
  • Net Margins: 2.40%
  • Return on Equity: 8.16%
  • Return on Assets: 4.32%
Debt:
  • Debt-to-Equity Ratio: 0.51%
  • Current Ratio: 1.98%
  • Quick Ratio: 1.10%
Misc:
  • Average Volume: 338,003 shs.
  • Beta: 1.78
  • Short Ratio: 11.18
 
Frequently Asked Questions for Halyard Health (NYSE:HYH)

What is Halyard Health's stock symbol?

Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."

How were Halyard Health's earnings last quarter?

Halyard Health, Inc. (NYSE:HYH) announced its earnings results on Tuesday, May, 2nd. The company reported $0.48 earnings per share for the quarter, beating analysts' consensus estimates of $0.43 by $0.05. The firm had revenue of $395.60 million for the quarter, compared to analyst estimates of $391.56 million. Halyard Health had a net margin of 2.40% and a return on equity of 8.16%. The company's revenue for the quarter was up 2.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.53 EPS. View Halyard Health's Earnings History.

What guidance has Halyard Health issued on next quarter's earnings?

Halyard Health updated its FY17 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of $1.70 - $2.00 for the period, compared to the Thomson Reuters consensus estimate of $1.84.

Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2017?

4 brokers have issued 12 month target prices for Halyard Health's stock. Their forecasts range from $35.00 to $45.00. On average, they expect Halyard Health's stock price to reach $39.33 in the next year. View Analyst Ratings for Halyard Health.

What are analysts saying about Halyard Health stock?

Here are some recent quotes from research analysts about Halyard Health stock:

  • 1. According to Zacks Investment Research, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. " (7/12/2017)
  • 2. Stifel Nicolaus analysts commented, "HYH closed 2016 with its fourth consecutive quarter of sales and EPS upside relative to both Consensus and management guidance. After a more difficult than expected first-year (2015) post-spin, in 2016, the company's transformation took clearer shape and was highlighted by: accretive M&A, a positive mix shift to the more profitable Medical Device franchise (38% of sales; 64% of operating profit), successful re-negotiations of material GPO contracts, significant organic cost-savings and stepped-up investments, all with significantly improved cash flow generation ($100M+ guide vs. $160M actual). We continue to believe HYH has further price appreciation potential ahead as '2016-like' thematic drivers continue playing out over the next 12-24 months. Still, we acknowledge that HYH shares (+56% TTM vs. S&P500: +23%) trading at 20x 2018E EPS (vs. large cap ~18x) could "pause" here as the stock absorbs the recent out-performance and the next wave of potentially positive catalysts becomes more visible. Yet to be realized sales, margin, and EPS-enhancing catalysts could include: IT cost savings, better S&IP pricing, more normal nitrile pricing and most important, further accretive M&A opportunities. Company-specific 2017 headwinds could include: more intense commodity price inflation, stepped up On-Q competition, and still uncertain macro tax-related legislation. For us, the bottom line is that HYH remains a positive long-term transformation story that is still in 'early innings' with significant opportunity both organically and through acquisitions to leverage earnings. We rate HYH Buy and raise our TP to $45 (from $38)." (2/28/2017)

Who are some of Halyard Health's key competitors?

Who are Halyard Health's key executives?

Halyard Health's management team includes the folowing people:

  • Robert E. Abernathy, Chairman of the Board
  • Joseph F. Woody, Chief Executive Officer, Director
  • Steven E. Voskuil, Chief Financial Officer, Senior Vice President
  • Christopher M. Lowery, Chief Operating Officer, Senior Vice President
  • Rhonda D. Gibby, Chief Human Resource Officer, Senior Vice President
  • John W. Wesley, Senior Vice President, General Counsel
  • Christopher G. Isenberg, Senior Vice President - Global Supply Chain and Procurement
  • Warren J. Machan, Senior Vice President - Business Strategy
  • Ronald W. Dollens, Lead Independent Director
  • Gary D. Blackford, Independent Director

Who owns Halyard Health stock?

Halyard Health's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Confluence Investment Management LLC (0.21%), Malaga Cove Capital LLC (0.12%), Aperio Group LLC (0.06%), Legacy Private Trust Co. (0.06%), Meyer Handelman Co. (0.06%) and Adams Diversified Equity Fund Inc. (0.05%). Company insiders that own Halyard Health stock include Robert E Abernathy and Steven E Voskuil. View Institutional Ownership Trends for Halyard Health.

Who sold Halyard Health stock? Who is selling Halyard Health stock?

Halyard Health's stock was sold by a variety of institutional investors in the last quarter, including Meyer Handelman Co., Legacy Private Trust Co., Adams Diversified Equity Fund Inc., Bank of Montreal Can, Meeder Asset Management Inc., US Bancorp DE and CENTRAL TRUST Co. View Insider Buying and Selling for Halyard Health.

Who bought Halyard Health stock? Who is buying Halyard Health stock?

Halyard Health's stock was acquired by a variety of institutional investors in the last quarter, including Confluence Investment Management LLC, Aperio Group LLC, Nisa Investment Advisors LLC, Oregon Public Employees Retirement Fund, Alpha Windward LLC, Malaga Cove Capital LLC, LS Investment Advisors LLC and Louisiana State Employees Retirement System. Company insiders that have bought Halyard Health stock in the last two years include Robert E Abernathy and Steven E Voskuil. View Insider Buying and Selling for Halyard Health.

How do I buy Halyard Health stock?

Shares of Halyard Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Halyard Health's stock price today?

One share of Halyard Health stock can currently be purchased for approximately $39.44.


MarketBeat Community Rating for Halyard Health (NYSE HYH)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  92 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about Halyard Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Halyard Health (NYSE:HYH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 3 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $39.33 (0.27% downside)

Analysts' Ratings History for Halyard Health (NYSE:HYH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
2/28/2017Stifel NicolausBoost Price TargetBuy$38.00 -> $45.00N/AView Rating Details
2/28/2017StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
1/6/2017JMP SecuritiesDowngradeOutperform -> Market Perform$38.00N/AView Rating Details
12/15/2016Deutsche Bank AGDowngradeBuy -> Hold$35.00N/AView Rating Details
12/18/2015KeyCorpInitiated CoverageSector WeightN/AView Rating Details
10/12/2015Morgan StanleyDowngradeEqual Weight -> Underweight$27.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Halyard Health (NYSE:HYH)
Earnings by Quarter for Halyard Health (NYSE:HYH)
Earnings History by Quarter for Halyard Health (NYSE HYH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/2/2017Q1 2017$0.43$0.48$391.56 million$395.60 millionViewListenView Earnings Details
2/27/2017Q416$0.44$0.50$401.72 million$410.00 millionViewListenView Earnings Details
11/2/2016Q316$0.39$0.48$387.64 million$398.00 millionViewN/AView Earnings Details
8/3/2016Q216$0.36$0.45$383.08 million$400.00 millionViewN/AView Earnings Details
5/4/2016Q116$0.34$0.53$369.80 million$385.00 millionViewN/AView Earnings Details
2/29/2016Q415$0.50$0.57$401.96 million$401.40 millionViewListenView Earnings Details
11/3/2015Q315$0.47$0.52$388.00 million$390.00 millionViewN/AView Earnings Details
8/4/2015Q215$0.53$0.52$401.70 million$389.30 millionViewN/AView Earnings Details
5/4/2015Q1 2015$0.64$0.51$390.00 million$394.00 millionViewN/AView Earnings Details
3/4/2015Q4$0.75$1.59$425.10 million$439.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Halyard Health (NYSE:HYH)
2017 EPS Consensus Estimate: $1.81
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$0.44$0.44$0.44
Q2 20171$0.40$0.40$0.40
Q3 20171$0.46$0.46$0.46
Q4 20171$0.51$0.51$0.51
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Halyard Health (NYSE:HYH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Halyard Health (NYSE:HYH)
Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 91.29%
Insider Trades by Quarter for Halyard Health (NYSE:HYH)
Institutional Ownership by Quarter for Halyard Health (NYSE:HYH)
Insider Trades by Quarter for Halyard Health (NYSE:HYH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/4/2015Robert E AbernathyCEOBuy10,000$31.06$310,600.00View SEC Filing  
9/1/2015Steven E VoskuilCFOBuy1,000$30.00$30,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Halyard Health (NYSE:HYH)
Latest Headlines for Halyard Health (NYSE:HYH)
Source:
DateHeadline
americanbankingnews.com logoHalyard Health, Inc. (HYH) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 18 at 8:47 PM
americanbankingnews.com logo$400.37 Million in Sales Expected for Halyard Health, Inc. (NYSE:HYH) This Quarter
www.americanbankingnews.com - July 14 at 1:24 PM
americanbankingnews.com logoZacks: Brokerages Expect Halyard Health, Inc. (NYSE:HYH) Will Post Earnings of $0.38 Per Share
www.americanbankingnews.com - July 12 at 4:16 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Downgraded by BidaskClub to Hold
www.americanbankingnews.com - July 8 at 6:32 PM
seekingalpha.com logoHalyard Health: Is A Major Divestiture In The Works? - Seeking Alpha - Seeking Alpha
seekingalpha.com - July 1 at 12:47 AM
americanbankingnews.com logoICU Medical (ICUI) and Halyard Health (HYH) Head to Head Analysis
www.americanbankingnews.com - June 28 at 6:28 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Upgraded to Buy at BidaskClub
www.americanbankingnews.com - June 28 at 6:14 PM
finance.yahoo.com logoCorporate News Blog - Halyard Health Views CEO Transition; Robert Abernathy Replaced by Joseph Woody from Acelity
finance.yahoo.com - June 26 at 7:35 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Stock Rating Upgraded by TheStreet
www.americanbankingnews.com - June 25 at 11:40 PM
prnewswire.com logoHalyard Health Announces CEO Transition - PR Newswire (press release)
www.prnewswire.com - June 24 at 6:10 PM
americanbankingnews.com logoHalyard Health, Inc. (HYH) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - June 23 at 6:34 PM
streetinsider.com logoHalyard Health (HYH) CEO Robert Abernathy to Retire; Board Appoints Joseph Woody as CEO Successor
www.streetinsider.com - June 23 at 6:02 PM
finance.yahoo.com logoHalyard Health Announces CEO Transition
finance.yahoo.com - June 23 at 6:02 PM
finance.yahoo.com logoAtlanta's Halyard Health names new CEO, who's getting $1M sign-on award
finance.yahoo.com - June 23 at 6:02 PM
americanbankingnews.com logo Analysts Anticipate Halyard Health, Inc. (HYH) Will Post Quarterly Sales of $400.37 Million
www.americanbankingnews.com - June 18 at 8:55 AM
americanbankingnews.com logo Analysts Expect Halyard Health, Inc. (HYH) Will Post Earnings of $0.39 Per Share
www.americanbankingnews.com - June 16 at 4:42 PM
finance.yahoo.com logoETFs with exposure to Halyard Health, Inc. : June 15, 2017
finance.yahoo.com - June 15 at 8:02 PM
reuters.com logoHalyard Health explores sale of hospital product unit: sources - Reuters
www.reuters.com - June 13 at 10:36 PM
reuters.com logoHalyard Health explores sale of hospital product unit: sources
www.reuters.com - June 12 at 6:26 PM
finance.yahoo.com logoHalyard Health explores sale of hospital product unit-sources
finance.yahoo.com - June 12 at 6:26 PM
finance.yahoo.com logoHalyard Health, Inc. breached its 50 day moving average in a Bullish Manner : HYH-US : June 9, 2017
finance.yahoo.com - June 9 at 9:46 AM
nasdaq.com logoHalyard Health (HYH) Shares Cross Above 200 DMA
www.nasdaq.com - June 2 at 7:12 PM
americanbankingnews.com logoHalyard Health Inc (HYH) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - May 29 at 6:50 PM
nasdaq.com logoHalyard Health (HYH) Expands CORGRIP System Product Line - Nasdaq
www.nasdaq.com - May 24 at 5:38 PM
seekingalpha.com logoHalyard Health (HYH) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow
seekingalpha.com - May 23 at 5:23 PM
finance.yahoo.com logoHalyard Health Introduces Expanded Sizes for CORGRIP* NG/NI Tube Retention System
finance.yahoo.com - May 22 at 10:57 AM
streetinsider.com logoHalyard Health (HYH) & Sustainable Solutions Announce Licensing Agreement for Hospital Products from Recycled ... - StreetInsider.com
www.streetinsider.com - May 19 at 10:21 AM
streetinsider.com logoHalyard Health (HYH) & Sustainable Solutions Announce Licensing Agreement for Hospital Products from Recycled Sterilization Wrap
www.streetinsider.com - May 18 at 9:31 AM
finance.yahoo.com logoHalyard Health and Sustainable Solutions Enter Licensing Agreement to Create Environmentally Conscious Hospital Products from Recycled Sterilization Wrap
finance.yahoo.com - May 18 at 9:31 AM
finance.yahoo.com logoHalyard Health Adds New Drainage System to Comprehensive Portfolio of Enteral Feeding Products
finance.yahoo.com - May 16 at 11:14 AM
finance.yahoo.com logoHalyard Health, Inc. to Present at Bank of America Merrill Lynch 2017 Healthcare Conference
finance.yahoo.com - May 11 at 6:25 PM
finance.yahoo.com logoHalyard Health and the ALS Association Team Up for 2017 Advocacy Conference
finance.yahoo.com - May 10 at 1:28 PM
finance.yahoo.com logoETFs with exposure to Halyard Health, Inc. : May 8, 2017
finance.yahoo.com - May 8 at 5:30 PM
americanbankingnews.com logoHalyard Health Inc (HYH) Rating Lowered to C at TheStreet
www.americanbankingnews.com - May 6 at 11:52 PM
americanbankingnews.com logoHalyard Health Inc (HYH) Receives $39.33 Average Target Price from Analysts
www.americanbankingnews.com - May 5 at 10:58 PM
finance.yahoo.com logoHalyard Health, Inc. :HYH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017
finance.yahoo.com - May 5 at 5:47 PM
americanbankingnews.com logoQ2 2017 Earnings Forecast for Halyard Health Inc (HYH) Issued By KeyCorp
www.americanbankingnews.com - May 5 at 8:28 AM
americanbankingnews.com logoHalyard Health Inc (HYH) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 5 at 12:04 AM
seekingalpha.com logoHalyard Health's (HYH) CEO Robert Abernathy on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 4 at 5:59 PM
finance.yahoo.com logoEdited Transcript of HYH earnings conference call or presentation 2-May-17 1:00pm GMT
finance.yahoo.com - May 3 at 10:26 PM
nasdaq.com logoHalyard Health (HYH) Shares Cross Below 200 DMA
www.nasdaq.com - May 3 at 5:25 PM
finance.yahoo.com logoKimberly-Clark Sues Halyard Over $454 Million Gown Verdict
finance.yahoo.com - May 3 at 5:25 PM
americanbankingnews.com logoHalyard Health (HYH) Receives News Sentiment Score of 0.43
www.americanbankingnews.com - May 3 at 10:34 AM
americanbankingnews.com logoHalyard Health Inc (HYH) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - May 2 at 8:26 PM
americanbankingnews.com logoHalyard Health Inc (HYH) Issues Quarterly Earnings Results
www.americanbankingnews.com - May 2 at 4:34 PM
americanbankingnews.com logoHalyard Health Inc (HYH) Releases FY17 Earnings Guidance
www.americanbankingnews.com - May 2 at 10:46 AM
finance.yahoo.com logoHalyard Health, Inc. Announces First Quarter 2017 Results
finance.yahoo.com - May 2 at 10:19 AM
finance.yahoo.com logoHalyard beats Street 1Q forecasts
finance.yahoo.com - May 2 at 10:19 AM
americanbankingnews.com logoHalyard Health Inc (HYH) Expected to Post Quarterly Sales of $391.86 Million
www.americanbankingnews.com - April 30 at 8:34 AM
americanbankingnews.com logoHalyard Health (HYH) Given News Sentiment Rating of 0.56
www.americanbankingnews.com - April 29 at 9:48 AM

Social

Chart

Halyard Health (HYH) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff